AI-based CT Body Composition Identifies Myosteatosis as Key Mortality Predictor in Asymptomatic Adults
Authors:
- Maxime NachitMNMaxime Nachit
- Yves HorsmansYHYves Horsmans
- Ronald M. SummersRSRonald M. Summers
- Isabelle A. LeclercqILIsabelle A. Leclercq
- Perry J. PickhardtPPPerry J. Pickhardt
Top Cited Papers
- 1 June 2023
- journal article
- research article
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 307 (5) , 222008
Abstract
Background Body composition data have been limited to adults with disease or older age. The prognostic impact in otherwise asymptomatic adults is unclear. Purpose To use artificial intelligence-based body composition metrics from routine abdominal CT scans in asymptomatic adults to clarify the association between obesity, liver steatosis, myopenia, and myosteatosis and the risk of mortality. Materials and Methods In this retrospective single-center study, consecutive adult outpatients undergoing routine colorectal cancer screening from April 2004 to December 2016 were included. Using a U-Net algorithm, the following body composition metrics were extracted from low-dose, noncontrast, supine multidetector abdominal CT scans: total muscle area, muscle density, subcutaneous and visceral fat area, and volumetric liver density. Abnormal body composition was defined by the presence of liver steatosis, obesity, muscle fatty infiltration (myosteatosis), and/or low muscle mass (myopenia). The incidence of death and major adverse cardiovascular events were recorded during a median follow-up of 8.8 years. Multivariable analyses were performed accounting for age, sex, smoking status, myosteatosis, liver steatosis, myopenia, type 2 diabetes, obesity, visceral fat, and history of cardiovascular events. Results Overall, 8982 consecutive outpatients (mean age, 57 years ± 8 [SD]; 5008 female, 3974 male) were included. Abnormal body composition was found in 86% (434 of 507) of patients who died during follow-up. Myosteatosis was found in 278 of 507 patients (55%) who died (15.5% absolute risk at 10 years). Myosteatosis, obesity, liver steatosis, and myopenia were associated with increased mortality risk (hazard ratio [HR]: 4.33 [95% CI: 3.63, 5.16], 1.27 [95% CI: 1.06, 1.53], 1.86 [95% CI: 1.56, 2.21], and 1.75 [95% CI: 1.43, 2.14], respectively). In 8303 patients (excluding 679 patients without complete data), after multivariable adjustment, myosteatosis remained associated with increased mortality risk (HR, 1.89 [95% CI: 1.52, 2.35]; P < .001). Conclusion Artificial intelligence-based profiling of body composition from routine abdominal CT scans identified myosteatosis as a key predictor of mortality risk in asymptomatic adults. © RSNA, 2023 Supplemental material is available for this article. See also the editorial by Tong and Magudia in this issue.Keywords
Funding Information
- Fund for Scientific Research (31618719)
- FNRS (PDR T.0141.19, CDR J.0119.22, PDR THEMA P.C006.22)
This publication has 45 references indexed in Scilit:
- Ectopic fat: a target for cardiometabolic risk managementExpert Review of Cardiovascular Therapy, 2016
- Computed tomography-defined muscle and fat wasting are associated with cancer clinical outcomesSeminars in Cell & Developmental Biology, 2016
- Lean body mass as an independent determinant of dose‐limiting toxicity and neuropathy in patients with colon cancer treated with FOLFOX regimensCancer Medicine, 2016
- Sarcopenic obesity and myosteatosis are associated with higher mortality in patients with cirrhosisJournal of Cachexia, Sarcopenia and Muscle, 2015
- Greater Skeletal Muscle Fat Infiltration Is Associated With Higher All-Cause and Cardiovascular Mortality in Older MenThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2015
- Natural History of Hepatic Steatosis: Observed Outcomes for Subsequent Liver and Cardiovascular ComplicationsAmerican Journal of Roentgenology, 2014
- Metabolically healthy obesity: epidemiology, mechanisms, and clinical implicationsThe Lancet Diabetes & Endocrinology, 2013
- Cancer Cachexia in the Age of Obesity: Skeletal Muscle Depletion Is a Powerful Prognostic Factor, Independent of Body Mass IndexJournal of Clinical Oncology, 2013
- Myopenia—a new universal term for muscle wastingJournal of Cachexia, Sarcopenia and Muscle, 2011
- Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based studyThe Lancet Oncology, 2008